The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis

Abstract Background The predictive value of ERCC1 for prognosis and sensitivity to platinum-based chemotherapy in patients with non-small cell lung cancer (NSCLC) remains controversial. This meta-analysis was performed to provide an assessment of whether expression variations of ERCC1 are associated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2010-10, Vol.70 (1), p.63-70
Hauptverfasser:	Chen, Sufeng, Zhang, Jie, Wang, Rui, Luo, Xiaoyang, Chen, Haiquan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - enzymology Chemotherapy DNA-Binding Proteins - biosynthesis DNA-Binding Proteins - deficiency Endonucleases - biosynthesis Endonucleases - deficiency ERCC1 Hematology, Oncology and Palliative Medicine Humans Lung Neoplasms - drug therapy Lung Neoplasms - enzymology Medical sciences Meta-analysis Non-small-cell lung Organoplatinum Compounds - administration & dosage Pneumology Pulmonary/Respiratory Survival Survival Rate Tumors Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!